Downloadable Slideset

Share

Program Content

Activities

  • Asparaginase Hypersensitivity
    Practical Considerations for Administration of Asparaginase-Based Therapy to Patients With ALL: Hypersensitivity or Intolerance or Inactivation?
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2022

    Expires: December 08, 2023

  • Asparaginase Toxicities
    Strategies to Mitigate Adverse Events With Asparaginase Treatment in Patients With ALL
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2022

    Expires: December 08, 2023

  • Pediatric ALL Tx for AYA and Adults
    Applying Lessons and Experience in Pediatric Patients to the Treatment of AYA and Adult Patients With ALL
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2022

    Expires: December 08, 2023

  • EP: Asparaginase for AYA/Adult ALL
    ExpressPoints: Acute Lymphoblastic Leukemia Discussion on the Use of Asparaginase Therapy in Young and Older Adults
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 20, 2022

    Expires: December 19, 2023

Faculty

cover img faculity

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Emily Curran, MD

Assistant Professor
Department of Internal Medicine
Division of Hematology and Oncology
University of Cincinnati Cancer Center
Cincinnati, Ohio

cover img faculity

Kjeld Schmiegelow, MD, DMSci

Professor
Department of Pediatric Oncology
Righospitalet University Hospital
Copenhagen, Denmark

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from

Jazz Pharmaceuticals Inc